MARKET

GSK

GSK

GSK PLC
NYSE
39.24
-0.17
-0.43%
After Hours: 39.35 +0.11 +0.28% 19:49 03/21 EDT
OPEN
39.29
PREV CLOSE
39.41
HIGH
39.50
LOW
39.14
VOLUME
4.02M
TURNOVER
--
52 WEEK HIGH
44.38
52 WEEK LOW
31.37
MARKET CAP
81.17B
P/E (TTM)
25.15
1D
5D
1M
3M
1Y
5Y
1D
Democrats warn Trump about consequences of HIV prevention cuts
Seeking Alpha · 1d ago
CDC vaccine meeting, delayed under RFK Jr., is rescheduled
Seeking Alpha · 1d ago
Cautious Outlook on GlaxoSmithKline Amid Competitive and Financial Challenges Justifies Sell Rating
TipRanks · 1d ago
UK Stocks-Factors to watch on March 21
Reuters · 1d ago
UPDATE 1-US vaccine advisory meeting rescheduled for April
Reuters · 1d ago
Former Texas congressman Burgess eyed as CDC director nominee - report
Seeking Alpha · 1d ago
U.S. boosts bird flu response with another $100M in funds
Seeking Alpha · 2d ago
GILD Stock Down on Report of Cut in HIV Prevention Spending
Barchart · 2d ago
More
About GSK
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its specialty medicines prevent and treat diseases, from human immunodeficiency virus (HIV) to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Its portfolio also includes the lead molecule IDRX-42, highly selective tyrosine kinase inhibitor (TKI) that is designed to improve patients with gastrointestinal stromal tumors (GIST).

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.